We use cookies to help provide you with the best possible online experience. By using this site, you agree that we may store and access cookies on your device. You can find out more about how to set your own preferences here.
Accept cookies
Wednesday 17 April 2019
Cerbios-Pharma Investing in New High-Potency AP...
Cerbios-Pharma SA is expanding its high-potency API (HPAPI) production and conjugation capabilities. Gabriel Haering, Chief Executive Officer, Cerbios-Pharma SA, outlined the expansion at the DCAT Week ’19 Member Company Announcement Forum, which was held March 18, 2019 in New...
Discover more
News Highlight
View all news
Monday 03 June 2019
Bio-International Convention 2019
Event Highlight
View all events
Chemical division
Chemical APIs and HPAIs Contract Development an...
With a long-term expertise in the development and industrial scale manufacturing of APIs and its know-how in handling High Potency Active Ingredients (HPAIs), Cerbios is the ideal and reliable...
Discover more
Chemical division
Doxercalciferol
Doxercalciferol is a synthetic Vitamin D2 Analog which regulates blood calcium at levels required for essential body functions. It acts on bone cells, (osteoblasts), to stimulate skeletal growth...
Discover more
Chemical division
Conjugation capabilities
Leveraging the synergies of Cerbios Chemical and Biological Divisions to create a unique  integrated service for ADC Drug Substance production.As a natural evolution of established competence in...
Discover more
Chemical division
Innovative Drug Delivery Systems based on Lipid...
AKVANO®  technology, based on a water-free liquid, opens up a new dimension in topical administration.AKVANO formulations consist of lipid components which are dissolved in a volatile, water-free...
Discover more
Biological division
Pharmaceutical probiotics: contract manufacturi...
Cerbios is considered to be a leading company worldwide in the field of probiotics for pharmaceutical use.Cerbios can offer its customers probiotics of pharmaceutical quality as well as contract...
Discover more